cytarabine and Digestive System Neoplasms

cytarabine has been researched along with Digestive System Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brugarolas, A; Buesa, JM; Gracia Marco, M; Lacave, AJ; Valle Pereda, M1
Markman, M1

Other Studies

2 other study(ies) available for cytarabine and Digestive System Neoplasms

ArticleYear
Phase I and II clinical study of anhydro-ara-5-fluorocytosine (AAFC) and ICRF-159 combination in adenocarcinoma of digestive origin.
    Cancer clinical trials, 1978,Winter, Volume: 1, Issue:4

    Topics: Adenocarcinoma; Adult; Aged; Ancitabine; Bone Marrow; Cytarabine; Digestive System Neoplasms; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Razoxane; Remission, Spontaneous

1978
Melphalan and cytarabine administered intraperitoneally as single agents and combination intraperitoneal chemotherapy with cisplatin and cytarabine.
    Seminars in oncology, 1985, Volume: 12, Issue:3 Suppl 4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Digestive System Neoplasms; Doxorubicin; Drug Evaluation; Female; Humans; Infusions, Parenteral; Male; Melphalan; Middle Aged; Ovarian Neoplasms; Peritoneal Cavity

1985